BIOARRAY Genetics' Series B - II Round

BIOARRAY Genetics raised a round of funding on September 26, 2017.

BIOARRAY Genetics, fka BIOARRAY Therapeutics, is developing a chemotherapy response assay designed to help guide physicians in the selection of the most effective treatment, the first time. Specifical…

Articles about BIOARRAY Genetics' Series B - II Round: